These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31340450)

  • 1. Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1.5 Million Patients.
    Masana L; Zamora A; Plana N; Comas-Cufí M; Garcia-Gil M; Martí-Lluch R; Ponjoan A; Alves-Cabratosa L; Elosua R; Marrugat J; Dégano IR; Ramos R
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31340450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.
    Perak AM; Ning H; de Ferranti SD; Gooding HC; Wilkins JT; Lloyd-Jones DM
    Circulation; 2016 Jul; 134(1):9-19. PubMed ID: 27358432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
    Duell PB; Gidding SS; Andersen RL; Knickelbine T; Anderson L; Gianos E; Shrader P; Kindt I; O'Brien EC; McCann D; Hemphill LC; Ahmed CD; Martin SS; Larry JA; Ahmad ZS; Kullo IJ; Underberg JA; Guyton J; Thompson P; Wilemon K; Roe MT; Rader DJ; Cuchel M; Linton MF; Shapiro MD; Moriarty PM; Knowles JW
    Atherosclerosis; 2019 Oct; 289():85-93. PubMed ID: 31487564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members.
    Zawacki AW; Dodge A; Woo KM; Ralphe JC; Peterson AL
    J Clin Lipidol; 2018; 12(6):1445-1451. PubMed ID: 30150142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substantially Elevated Atherosclerotic Risks in Japanese Severe Familial Hypercholesterolemia Defined by the International Atherosclerosis Society.
    Funabashi S; Kataoka Y; Hori M; Ogura M; Nakaoku Y; Nishimura K; Doi T; Nishikawa R; Tsuda K; Noguchi T; Harada-Shiba M
    JACC Asia; 2021 Sep; 1(2):245-255. PubMed ID: 36338164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia.
    Paquette M; Cariou B; Bernard S; Hegele RA; Gallo A; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
    Arterioscler Thromb Vasc Biol; 2024 Feb; 44(2):505-512. PubMed ID: 38031840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of severe hypercholesterolemia and familial hypercholesterolemia in a population-based setting in the US.
    Saadatagah S; Alhalabi L; Farwati M; Zordok M; Bhat A; Smith CY; Wood-Wentz CM; Bailey KR; Kullo IJ
    Am J Prev Cardiol; 2022 Dec; 12():100393. PubMed ID: 36204653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
    Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J
    Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of 3-year statin therapy and the achievement of LDL cholesterol target values in familial hypercholesterolemia patients: An experience from Serbia.
    Lalić K; Rajković N; Popović L; Lukač SS; Stošić L; Rasulić I; Lalić NM
    Atherosclerosis; 2018 Oct; 277():298-303. PubMed ID: 30270062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical Characteristics.
    Altschmiedova T; Todorovova V; Vrablik M; Ceska R
    Front Genet; 2022; 13():849267. PubMed ID: 35368707
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy.
    Miname MH; Bittencourt MS; Moraes SR; Alves RIM; Silva PRS; Jannes CE; Pereira AC; Krieger JE; Nasir K; Santos RD
    JACC Cardiovasc Imaging; 2019 Sep; 12(9):1797-1804. PubMed ID: 30448145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
    Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P
    Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk factor profiles in familial hypercholesterolemia patients with and without genetic mutation compared to a nationally representative sample of adults in a high-risk European country.
    Chlebus K; Zdrojewski T; Gruchała M; Gałąska R; Pajkowski M; Kocejko MR; Chmara M; Pencina MJ
    Am Heart J; 2019 Dec; 218():32-45. PubMed ID: 31706143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial hypercholesterolemia and atherosclerotic cardiovascular mortality among Korean adults with low levels of serum cholesterol.
    Jung KJ; Koh H; Choi Y; Lee SJ; Ji E; Jee SH
    Atherosclerosis; 2018 Nov; 278():103-109. PubMed ID: 30261470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemia.
    Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A
    J Clin Lipidol; 2023; 17(3):376-383. PubMed ID: 37003850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Features and Gaps in the Management of Probable Familial Hypercholesterolemia and Cardiovascular Disease.
    Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C
    Circ J; 2017 Dec; 82(1):218-223. PubMed ID: 28701632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-related differences in premature cardiovascular disease in familial hypercholesterolemia.
    Agarwala A; Deych E; Jones LK; Sturm AC; Aspry K; Ahmad Z; Ballantyne CM; Goldberg AC
    J Clin Lipidol; 2023; 17(1):150-156. PubMed ID: 36470719
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.